{"nct_id":"NCT04919512","title":"A Study of TAR-200 in Combination With Cetrelimab and Cetrelimab Alone in Participants With Muscle-Invasive Urothelial Carcinoma of the Bladder","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-09","start_date":"2022-07-07","start_date_type":"ACTUAL","primary_completion_date":"2025-01-31","primary_completion_date_type":"ACTUAL","completion_date":"2027-03-07","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["JNJ"]}